Register | Login

Ients with advanced ovarian carcinoma? Am J Obstet Gynecol. 2014;211(3):231. e231?39. 3. Martin LP, Sill M, Shahin MS, Powell M, DiSilvestro P, Landrum LM, et al. A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2014;132(3):526?0. 4. Matsu

Who Voted for this Story


Instant Approval Social Bookmarking List

Instant Approval Social Bookmarking List

Pligg is an open source content management system that lets you easily create your own social network.